Category: Include on Menu
-
What Is the Biggest Obstacle to a SpaceX-Tesla Merger? JPMorgan Points to China
Why does JPMorgan consider Chinese regulatory approval the main obstacle to a SpaceX-Tesla merger? JPMorgan believes obtaining regulatory approval in China could represent the most significant challenge to a potential merger between Tesla (NASDAQ:TSLA) and SpaceX, outweighing the difficulties associated with securing support from Tesla shareholders. In a research note published Wednesday, JPMorgan analyst Rajat…
-
US Stock Futures Drop After Tesla, Meta & IBM Earnings Drop: Dow Jones, S&P and Nasdaq Futures
U.S. index futures point to a sharply lower open on Thursday as investors take profits from Tesla, Meta, and IBM following earnings, alongside growing AI capital spending concerns. Dow Jones, S&P 500 and Nasdaq futures are currently pointing to a sharply lower open on Thursday, with stocks likely to give back ground after trending higher…
-
U.S. Jobless Claims Drop to 194K vs. 200K Expected in Surprise Labor Market Strength
U.S. initial unemployment claims fell to 194,000 for the week ended Oct. 17, beating expectations as layoffs remain near multi-decade lows. First-time claims for U.S. unemployment benefits unexpectedly declined in the week ended October 17th, according to a report released by the Labor Department on Thursday. The report said initial jobless claims fell to 194,000,…
-
Is the AI Stock Market Bubble Close to Bursting? Yardeni Research Says Risks Remain Limited
Does Yardeni Research believe there is an AI stock market bubble? Yardeni Research believes that artificial intelligence-related stocks are showing characteristics of a market bubble, although its latest analysis suggests that the conditions associated with a major market correction are not yet fully established. In a research note published this week, the firm introduced an…
-
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission, PDUFA Date of March 25, 2027
Unicycive Therapeutics, Inc. (Nasdaq: UNCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of its New Drug Application (NDA) for oxylanthanum carbonate (OLC), the Company’s investigational oral phosphate binder for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis.
-
Tech Rally Lifts Wall Street as SpaceX Surges
U.S. stocks finished higher on Wednesday, with technology shares leading the way as investors cheered strong quarterly results from SpaceX and positioned ahead of earnings from Tesla and Meta after the closing bell. All three major averages gained despite a jump in oil prices tied to an attack on a Saudi Aramco field, suggesting investors…
-
Software stocks gain as market warning signals flash
Bruce Campbell examines the rotation from semiconductors into software, weakening US banking stocks and fresh warning signals across equity markets.
-
Manufacturing Progress Gives INmune Bio a Clearer UK Filing Path for Ebstrocel
INmune Bio (NASDAQ:INMB) is advancing its European commercialization strategy for Ebstrocel, leveraging chemistry, manufacturing, and controls (CMC) progress to streamline its regulatory timeline and accelerate potential entry into the UK market. By submitting its final pre-marketing authorization application (pre-MAA) package to the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), the biotechnology company confirmed a…
-
Why Is Netflix Stock Falling Over 5% Despite Beating Third-Quarter Earnings Estimates?
Why did Netflix shares decline in pre-market trading? Netflix (NASDAQ:NFLX) shares fell more than 5% in pre-market trading after the streaming company issued fourth-quarter revenue guidance below Wall Street expectations, despite reporting third-quarter earnings above analysts’ forecasts. The company also reduced its annual advertising revenue outlook, citing delays in the introduction of certain advertising products.…
-
How Is NVIDIA Expanding AI-Powered Telecom Networks Following T-Mobile’s First AI-RAN Call?
What did T-Mobile and NVIDIA announce at GTC Berlin? NVIDIA (NASDAQ:NVDA) announced at its GTC Berlin event that T-Mobile US (NASDAQ:TMUS) had completed what the companies described as the world’s first AI Radio Access Network (AI-RAN) call on a commercial mobile network. The demonstration took place in Bellevue, Washington, in collaboration with NVIDIA and Nokia…